We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+31.61%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$561M
AUM Growth
+$315M
Cap. Flow
+$248M
Cap. Flow %
44.2%
Top 10 Hldgs %
35.2%
Holding
112
New
30
Increased
42
Reduced
5
Closed
33

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$16.6M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$12.9M
3
MDCO
Medicines Co
MDCO
+$12.8M
4
AMGN icon
Amgen
AMGN
+$12.7M
5
BIIB icon
Biogen
BIIB
+$12.6M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$6.11M
2
HCA icon
HCA Healthcare
HCA
+$3.85M
3
ILMN icon
Illumina
ILMN
+$3.51M
4
ELV icon
Elevance Health
ELV
+$2.58M
5
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$2.02M

Sector Composition

Rank Sector Weight
1 Healthcare 73.05%
2 Energy 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUPN icon
26
Supernus Pharmaceuticals
SUPN
$2.73B
$7.42M 1.32%
300,000
+75,000
+33% +$1.7M
BMY icon
27
Bristol-Myers Squibb
BMY
$130B
$7.01M 1.25%
+130,000
New +$8.35M
MRUS
28
DELISTED
Merus
MRUS
$6.7M 1.19%
400,000
+200,000
+100% +$1.9M
GWPH
29
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$6.64M 1.18%
+50,000
New +$4.78M
CI icon
30
CALL
Cigna
CI
$72.4B
$6.52M 1.16%
50,000
+25,000
+100% +$3.26M
NERV icon
31
Minerva Neurosciences
NERV
$206M
$6.35M 1.13%
56,250
+40,625
+260% +$3.94M
ELV icon
32
Elevance Health
ELV
$84.7B
$6.27M 1.12%
50,000
-20,000
-29% -$2.58M
LLY icon
33
CALL
Eli Lilly
LLY
$1.08T
$6.02M 1.07%
+75,000
New +$6M
MDRX
34
DELISTED
Veradigm Inc. Common Stock
MDRX
$5.93M 1.06%
450,000
+200,000
+80% +$2.67M
KTWO
35
DELISTED
K2M Group Holdings, Inc
KTWO
$5.87M 1.05%
330,000
+190,000
+136% +$3.19M
SPNC
36
DELISTED
Spectranetics Corp
SPNC
$5.52M 0.98%
220,000
+110,000
+100% +$2.57M
GWPH
37
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.31M 0.95%
+40,000
New +$3.82M
GBT
38
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.25M 0.94%
+100,000
New +$1.91M
PCRX icon
39
Pacira BioSciences
PCRX
$972M
$5.13M 0.92%
+150,000
New +$5.88M
AVDL
40
DELISTED
Avadel Pharmaceuticals
AVDL
$4.96M 0.88%
400,000
+325,000
+433% +$4.25M
ALDR
41
DELISTED
Alder Biopharmaceuticals
ALDR
$4.92M 0.88%
+150,000
New +$4.57M
AERI
42
PUT
DELISTED
Aerie Pharmaceuticals
AERI
$4.91M 0.87%
+130,000
New +$2.87M
LHCG
43
DELISTED
LHC Group LLC
LHCG
$4.79M 0.85%
+130,000
New +$5.21M
IPXL
44
DELISTED
Impax Laboratories, Inc.
IPXL
$4.74M 0.85%
+200,000
New +$5.38M
TVTX icon
45
Travere Therapeutics
TVTX
$5.68B
$4.48M 0.8%
+200,000
New +$3.81M
OPCH icon
46
Option Care Health
OPCH
$3.61B
$4.34M 0.77%
375,000
+187,500
+100% +$2.02M
PMC
47
DELISTED
PharMerica Corporation
PMC
$4.21M 0.75%
150,000
+85,000
+131% +$2.18M
AXDX
48
DELISTED
Accelerate Diagnostics
AXDX
$4.09M 0.73%
15,000
– –
IONS icon
49
Ionis Pharmaceuticals
IONS
$9.21B
$3.66M 0.65%
+100,000
New +$3.13M
ACHC icon
50
Acadia Healthcare
ACHC
$2.9B
$3.47M 0.62%
+70,000
New +$3.65M
1
2
3 4 5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2016 Portfolio in Review

As of Q3 2016, Iguana Healthcare Management held 112 positions worth $561M, up 128% from $246M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Iguana Healthcare Management deployed $248M of net new capital in Q3 2016, opening 30 new positions and adding to 42 existing holdings. Its largest new stake was Bristol-Myers Squibb: 130,000 shares worth $7.01M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 78% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was Elevance Health, an estimated $2.58M trimmed.

  • Iguana Healthcare Management's largest Q3 2016 buy was Bristol-Myers Squibb: 130,000 shares worth $7.01M.
  • Iguana Healthcare Management added most to Ultragenyx Pharmaceutical in Q3 2016, an estimated $16.6M increase.
  • Iguana Healthcare Management's biggest Q3 2016 reduction was Elevance Health, cutting an estimated $2.58M.
  • Iguana Healthcare Management fully exited Baxter International in Q3 2016, selling an estimated $6.11M.
  • Iguana Healthcare Management's ten largest holdings make up 35% of its $561M portfolio in Q3 2016.
  • Iguana Healthcare Management opened 30 new positions and closed 33 in Q3 2016.
  • Iguana Healthcare Management's portfolio value rose 128% quarter-over-quarter to $561M.

Based on Iguana Healthcare Management's 13F filing for Q3 2016, filed 14 Nov 2016.